Galapagos Genomics NV Expands Chemistry Services Through Contracts With Indian Companies

MECHELEN, BELGIUM--(MARKET WIRE)--Jun 23, 2006 -- Indus BioSciences and Sanmar Speciality Chemicals to support BioFocus DPI Mechelen, Belgium; 23 June, 2006 - Galapagos NV (Euronext & LSE: GLPG), a genomics-based drug discovery company, announced today that its service division BioFocus DPI has signed collaborations with Indus Biosciences, a subsidiary of CiVentiChem LLC in Hyderabad, and ProCitius, a division of Sanmar Speciality Chemicals Limited in Chennai, both providers of integrated chemistry services to life sciences companies. Both companies will carry out chemistry services for the BioFocus DPI Discovery Products division, with an option to provide support for client projects conducted by the BioFocus DPI Medicinal Chemistry division.

MORE ON THIS TOPIC